Physician profile
Nicholas Mata
NPI 1750736658
$1,762.98
in general payments reported to CMS, 2019-2025
8 companies · $21.12 in 2025
The $21.12 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $748 · 2023: $402 · 2024: $327 · 2025: $21.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $924.85 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept |
| Nevro Corp. | $342.95 | 2021-2023 | Senza |
| Mml US, INC. | $194.32 | 2023 | Reactiv8 |
| Vertos Medical, INC. | $148.06 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $64.23 | 2023-2024 | Evoke Scs, Evoke |
| Abbott Laboratories | $36.90 | 2024 | Eterna |
| Si-Bone, INC. | $28.92 | 2024 | |
| Fidia Pharma USA INC. | $22.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.